SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-020481
Filing Date
2015-03-17
Accepted
2015-03-17 16:53:01
Documents
6
Period of Report
2015-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-6136_58k.htm 8-K 42352
2 EX-1.1 a15-6136_5ex1d1.htm EX-1.1 353403
3 EX-5.1 a15-6136_5ex5d1.htm EX-5.1 12545
4 EX-99.1 a15-6136_5ex99d1.htm EX-99.1 9929
5 GRAPHIC g61365kii001.jpg GRAPHIC 1980
6 GRAPHIC g61366mmi001.jpg GRAPHIC 4765
  Complete submission text file 0001104659-15-020481.txt   429036
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 15707426
SIC: 2834 Pharmaceutical Preparations